The temporal context of oral anticoagulation outcome in atrial fibrillation.
作者信息
Fender Anke C, Dobrev Dobromir
机构信息
Institute of Pharmacology, Medical Faculty, University Duisburg-Essen, Germany.
Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, Canada.
出版信息
Int J Cardiol Heart Vasc. 2022 May 13;40:101051. doi: 10.1016/j.ijcha.2022.101051. eCollection 2022 Jun.
Abstract
摘要
相似文献
1
The temporal context of oral anticoagulation outcome in atrial fibrillation.
Int J Cardiol Heart Vasc. 2022 May 13;40:101051. doi: 10.1016/j.ijcha.2022.101051. eCollection 2022 Jun.
2
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED).
Ann Emerg Med. 2019 Apr;73(4):382-392. doi: 10.1016/j.annemergmed.2018.09.001. Epub 2018 Oct 26.
3
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23.
4
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4.
5
Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation.
J Neurol Sci. 2013 Nov 15;334(1-2):139-42. doi: 10.1016/j.jns.2013.08.013. Epub 2013 Aug 15.
6
Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study.
Int J Stroke. 2013 Apr;8(3):150-4. doi: 10.1111/j.1747-4949.2011.00716.x. Epub 2011 Dec 14.
7
[Anticoagulation with atrial fibrillation].
Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):89-94. doi: 10.1007/s00399-006-0515-z.
8
Increasing rate of atrial fibrillation from 2003 to 2011 in patients with ischaemic stroke: results from 55,551 patients in a nationwide registry.
Eur J Neurol. 2015 May;22(5):839-44. doi: 10.1111/ene.12671. Epub 2015 Feb 12.
9
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.
10
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
引用本文的文献
1
Recent highlights from the on challenges for adequate stroke prevention in patients with atrial fibrillation.
Int J Cardiol Heart Vasc. 2023 Aug 21;48:101259. doi: 10.1016/j.ijcha.2023.101259. eCollection 2023 Oct.
本文引用的文献
1
On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects.
Int J Cardiol Heart Vasc. 2022 Apr 4;40:101024. doi: 10.1016/j.ijcha.2022.101024. eCollection 2022 Jun.
2
Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study.
J Am Heart Assoc. 2022 Mar 15;11(6):e024119. doi: 10.1161/JAHA.121.024119. Epub 2022 Mar 1.
3
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.
Eur Heart J Suppl. 2022 Feb 14;24(Suppl A):A42-A55. doi: 10.1093/eurheartj/suab152. eCollection 2022 Feb.
4
Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?
J Thromb Haemost. 2022 Feb;20(2):339-352. doi: 10.1111/jth.15592. Epub 2021 Nov 23.
5
Anticoagulation trends in adults aged 65 years and over with atrial fibrillation: a cohort study.
Open Heart. 2021 Aug;8(2). doi: 10.1136/openhrt-2021-001737.
6
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries.
Europace. 2021 Nov 8;23(11):1722-1730. doi: 10.1093/europace/euab091.
7
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
J Clin Med. 2020 Jun 23;9(6):1969. doi: 10.3390/jcm9061969.
8
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.
Res Pract Thromb Haemost. 2019 Oct 24;4(1):141-153. doi: 10.1002/rth2.12261. eCollection 2020 Jan.
9
Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
Heart. 2020 Jan;106(2):119-126. doi: 10.1136/heartjnl-2019-315307. Epub 2019 Oct 10.
10
Evaluating utilization patterns of oral anticoagulants in routine care.
J Thromb Haemost. 2019 Jul;17(7):1033-1043. doi: 10.1111/jth.14467. Epub 2019 May 29.
Zotero 插件